Home > Insider Trading > Filing (0001209191-17-046030)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1197032	F Ian Smith	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp, Cfo & Coo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-07-19	25,500	$96.87	151,738	No	4	M	Direct
Common Stock	Acquisiton	2017-07-19	10,775	$91.05	162,513	No	4	M	Direct
Common Stock	Acquisiton	2017-07-19	55,250	$77.31	217,763	No	4	M	Direct
Common Stock	Acquisiton	2017-07-19	31,875	$83.36	249,638	No	4	M	Direct
Common Stock	Disposition	2017-07-19	123,400	$161.00	126,238	No	4	S	Direct
Common Stock	Disposition	2017-07-21	400	$157.56	125,838	No	4	S	Direct
Common Stock	Disposition	2017-07-21	1,829	$158.62	124,009	No	4	S	Direct
Common Stock	Disposition	2017-07-21	815	$159.61	123,194	No	4	S	Direct
Common Stock	Disposition	2017-07-21	2,000	$161.01	121,194	No	4	S	Direct
Common Stock	Disposition	2017-07-21	5,106	$161.71	116,088	No	4	S	Direct
Common Stock	Disposition	2017-07-21	200	$162.40	115,888	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2017-07-19	25,500	$0.00	25,500	$96.87
Common Stock	Stock Option (Right to Buy)	Disposition	2017-07-19	10,775	$0.00	10,775	$91.05
Common Stock	Stock Option (Right to Buy)	Disposition	2017-07-19	55,250	$0.00	55,250	$77.31
Common Stock	Stock Option (Right to Buy)	Disposition	2017-07-19	31,875	$0.00	31,875	$83.36

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
8,500	2024-07-14	No	4	M	Direct
23,707	2026-02-01	No	4	M	Direct
12,750	2024-02-04	No	4	M	Direct
2,125	2023-07-29	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,306	Indirect	401k

Footnotes

Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $157.56 (range $156.99 to $157.90).
Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $158.62 (range $158.11 to $159.09).
Open market sales reported on this line occurred at a weighted average price of $159.61 (range $159.16 to $159.90).
Open market sales reported on this line occurred at a weighted average price of $161.01 (range $160.28 to $161.24).
Open market sales reported on this line occurred at a weighted average price of $161.71 (range $161.28 to $162.20).
Open market sales reported on this line occurred at a weighted average price of $162.40 (range $162.39 to $162.40).
The option vests in 16 quarterly installments from 7/15/2014.
The option vests in 16 quarterly installments from 02/02/2016.
The option vests in 16 quarterly installments from 02/05/2014.
The option vests in 16 quarterly installments from 07/30/2013.